Federal Court Allows Vanda Pharmaceuticals’ Lawsuit to Proceed Against the U.S. Food and Drug Administration

WASHINGTON, Jan. 19, 2024 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the United States Court of Federal Claims in Washington, D.C. denied in part the government’s motion to dismiss Vanda’s claim against the United States for the Food and Drug…